Douglas Koppel, MD
Procedural Dermatology · Metairie, LANPI 1376616409
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (42.2%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by Galderma Laboratories, L.p. at 33.9% of the total. 2025 is the largest year on record at $35,132, more than ten times the $1,928 reported in 2019.
Across 969 payments — averaging $77.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$25K
- Arcutis Biotherapeutics, Inc.$22K
- Kowa Pharmaceuticals America, Inc.$8K
- Johnson & Johnson$4K
- AbbVie$2K
- Sanofi$2K
- plus $12K from 32 others
What the payments were for
- Consulting fees$19,38826%
- Speaking & faculty fees$31,70042%
- Travel & lodging$6,1838%
- Food & beverage$17,03923%
- Education$7661%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZORYVE$28,700
- AKLIEF$7,700
- Tremfya$2,343
- Neo-Synalar$700
- Clindacin P$350
- Tovet (emollient formulation)$350
- QBREXZA$250
- Accutane$250
- LITFULO$125
- VTAMA$105
How this compares
Too few procedural dermatology providers in Louisianato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 317 | $8,044 |
| Tacrolimus | 24 | $6,777 |
| CiclopiroxCiclopirox Olamine | 254 | $5,225 |
| Mometasone Furoate | 236 | $4,219 |
| Ketoconazole | 318 | $3,575 |
| Hydrocortisone | 213 | $2,988 |
| Metronidazole | 69 | $2,920 |
| Doxycycline Hyclate | 169 | $2,887 |
| Ammonium Lactate | 150 | $2,552 |
| Triamcinolone Acetonide | 195 | $2,451 |
| Clindamycin Phosphate | 84 | $1,675 |
| Finasteride | 103 | $1,577 |
| Imiquimod | 28 | $1,060 |
| ValacyclovirValacyclovir Hcl | 61 | $907 |
| Ciclopirox | 48 | $886 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Metairie
- Rene KoppelMetairie$6K
- William ColemanMetairie$5K
- Carter PaddockMetairie$4K
- William ColemanMetairie$2K
- Mary LupoNew Orleans$91K
- Jack Murphyla Place$6K
- Maurice VickBaton Rouge$5K
- Gordon RussoGretna$3K
- Michael LindleyNew Orleans$1K
- Chad PratherBaton Rouge$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.